ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
COVID vaccines

Thai king-owned biotech starts production of AstraZeneca vaccine

Plans call for exports to other ASEAN countries as soon as next month

A picture of the Thai royals stands near a Siam Bioscience factory outside Bangkok.   © Reuters

BANGKOK -- Siam Bioscience, a Thai drugmaker owned by the royal family, has started the country's first production of a COVID-19 vaccine, using AstraZeneca's technology.

The shots will be supplied for domestic use. Shipment volumes and other details have not been disclosed, but Public Health Minister Anutin Charnvirakul said on Tuesday that 6 million doses would be delivered this month, according to the Bangkok Post.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more